SCHEMBL3607269

SCHEMBL3607269

O=[N+]([O-])c1c[nH]c(S)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64072 0.77 CYP3A4 (0.33) —
SCHEMBL28920099 0.77 ALDH1A1 (0.33) —
SCHEMBL27960253 0.76 CYP3A4 (0.32) —
SCHEMBL28013804 0.76 CYP3A4 (0.32) —
SCHEMBL9627673 0.76 — —
SCHEMBL28819045 0.76 CYP3A4 (0.32) —
SCHEMBL28013221 0.76 CYP3A4 (0.32) —
SCHEMBL1853410 0.74 — —
SCHEMBL7555586 0.74 — —
SCHEMBL1849999 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2644599-A1 Method for preparing 1-substituted-4-nitroimidazole compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-10-02 — — EP disclosed
US-20100048555-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS MERCK SHARP & DOHME LIMITED (GB) 2010-02-25 — — US disclosed
EP-2046803-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS Merck Sharp &amp; Dohme Limited (GB) 2009-04-15 — — EP disclosed
WO-2008012571-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS MERCK SHARP & DOHME LIMITED (GB) 2008-01-31 — — WO disclosed
Send feedback